Analysis of human breast cancer specimens showed a lower level of ETS1 through hyper-DNA methylation on the ETS1 promoter region in BRCA compared to normal specimens, which was closely correlated with poor prognosis in a large number of BRCA patients. The gene discussed is ETS1; the disease is breast carcinoma.